Business
AI summaryEuroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in human and veterinary medicines across France, Europe, North America, Asia Pacific, and internationally. It operates as a contract development and manufacturing organization using technologies such as solid-phase chemistry, particle engineering, microbial fermentation, and small-molecule synthesis, and offers API solutions including vitamin B12, prostaglandins, corticoids and hormones, and anti-infectives. Its customers include pharmaceutical laboratories, generic and animal health manufacturers, and consumer health, nutrition, and cosmetics companies.
